The brain cancer treatment aid 5-ALA is now available to patients across England.
The treatment aid 5-aminolevulinic acid (5-ALA) otherwise known as ‘the pink drink’ uses fluorescent dye and ultraviolet light, enabling the cancerous cells to be identified with accuracy. Neurosurgeons can then achieve a higher percentage of successful tumour removals as a result.
5-ALA is part of the NHS Long Term Plan aim of saving more lives by detecting cancers earlier and starting treatment sooner.
It is estimated that as many as 2,000 patients a year could benefit from 5-ALA treatment.
It is hoped that by 2028, an additional 55,000 people each year will survive for 5 years following their cancer diagnosis.
Speaking on the new treatment, Secretary of state for Health and Social Care Matt Hancock said:
“As part of our Long Term Plan, this new pioneering technology is already saving lives – offering thousands of patients a greater chance of recovery and hope for the future.”
You can find out more about the 5-ALA treatment here.